Luminor Medical Technologies Inc  

(Public, CVE:LMT)   Watch this stock  
Find more results for cve:mom
0.205
-0.025 (-10.87%)
May 20 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.20 - 0.20
52 week 0.18 - 0.35
Open 0.20
Vol / Avg. 5,520.00/8,724.00
Mkt cap 414,234.00
P/E     -
Div/yield     -
EPS -1.90
Shares 2.02M
Beta 0.24
Inst. own     -

Key stats and ratios

Q4 (Nov '15) 2015
Net profit margin - -35914.64%
Operating margin - -30978.80%
EBITD margin - -19607.43%
Return on average assets -609.57% -220.52%
Return on average equity - -
CDP Score - -

Address

6-1250 Waverley St
WINNIPEG, MB R3T 6C6
Canada
+1-204-4531408 (Phone)
+1-204-4531546 (Fax)

Website links

Description

Luminor Medical Technologies Inc, formerly Miraculins Inc, is a Canada-based medical diagnostic company. It focuses on acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. The Company’s main products are Scout DS and PreVu. The Scout DS device is a diabetes screening and clinical tool that uses visible light to fluoresce and detect biomarkets present in the skin associated with both prediabetes and type 2 diabetes, and is a non-invasive testing system that does not require blood draw. PreVu is a skin cholesterol test that that measures cholesterol levels in the skin.

Officers and directors

Harry J F Bloomfield Independent Chairman of the Board
Age: 70
Christian Sauvageau President, Chief Executive Officer, Director
Christopher A. Carmichael CPA Chief Financial Officer
Ashwath Mehra Director